MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R - 药物、适应症、专利

基本信息

关联

1

项与 MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R 相关的药物

Modimelanotide

靶点

Bacterial DNA gyrase x MC1R x MC3R x MC4R x MC5R

作用机制

细菌DNA旋转酶复合体抑制剂 [+4]

在研机构

原研机构

在研适应症

非在研适应症

最高研发阶段临床前

首次获批国家/地区-

首次获批日期1800-01-20

6

项与 MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R 相关的临床试验

NCT01897519

/ Terminated临床2期

A Phase 2b, Randomized, Double-Blind, Placebo Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Major Surgery

This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

开始日期2013-05-01

申办/合作机构

AbbVie, Inc.

NCT01777165

/ Completed临床2期

A Phase 2b, Randomized, Double-Blind,Placebo-Controlled, Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Cardiac Surgery

This study will evaluate the safety and efficacy of ABT-719 in preventing acute kidney injury in patients undergoing high risk cardiac surgery.

开始日期2013-02-01

申办/合作机构

AbbVie, Inc.

EUCTR2010-022630-92-DK

/ Not yet recruitingN/A

An Explorative Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Trial of two Dosing Regimens of AP214 for the Prevention of Kidney Injury in Patients Undergoing Cardiac Surgery

开始日期2010-11-05

申办/合作机构

Action Pharma A/S

100 项与 MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R 相关的临床结果

登录后查看更多信息

100 项与 MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R 相关的转化医学

登录后查看更多信息

0 项与 MC5R x MC3R x MC4R x Bacterial DNA gyrase x MC1R 相关的专利（医药）

登录后查看更多信息

分析

对领域进行一次全面的分析。

登录

或

查看完整样例数据